Hypercalcaemia in osteogenesis imperfecta treated with pamidronate

Title

Hypercalcaemia in osteogenesis imperfecta treated with pamidronate

Creator

Williams CJ; Smith RA; Ball RJ; Wilkinson H

Publisher

Archives Of Disease In Childhood

Date

1997

Subject

Humans; Male; adolescent; Diphosphonates/therapeutic use; Recurrence; Hypercalcemia/drug therapy/etiology; Fractures; Osteogenesis Imperfecta/complications; Spontaneous/complications

Description

The response to the bisphosphonate, pamidronate, is reported in a child with osteogenesis imperfecta who had recurrent symptomatic hypercalcaemia after immobilisation following fractures. Oral clodronate was effective in the prevention of immobilisation hypercalcaemia in the same child. The bisphosphonates may have other roles in osteogenesis imperfecta by decreasing bone turnover.
1997

Rights

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Type

Journal Article

Citation List Month

Backlog

Citation

Williams CJ; Smith RA; Ball RJ; Wilkinson H, “Hypercalcaemia in osteogenesis imperfecta treated with pamidronate,” Pediatric Palliative Care Library, accessed October 4, 2022, https://pedpalascnetlibrary.omeka.net/items/show/11904.

Social Bookmarking